| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Dual specificity mitogen-activated protein kinase kinase 4 |
|---|
| Ligand | BDBM50336457 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_887643 (CHEMBL2217252) |
|---|
| IC50 | >3000±n/a nM |
|---|
| Citation |  Barf, T; Kaptein, A Irreversible protein kinase inhibitors: balancing the benefits and risks. J Med Chem55:6243-62 (2012) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Dual specificity mitogen-activated protein kinase kinase 4 |
|---|
| Name: | Dual specificity mitogen-activated protein kinase kinase 4 |
|---|
| Synonyms: | JNK-activating kinase 1 | JNKK | JNKK1 | MAP kinase kinase 4 | MAP2K4 | MEK4 | MKK4 | MP2K4_HUMAN | PRKMK4 | SAPK/ERK kinase 1 | SEK1 | SERK1 | SKK1 | c-Jun N-terminal kinase kinase 1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 44294.29 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1460558 |
|---|
| Residue: | 399 |
|---|
| Sequence: | MAAPSPSGGGGSGGGSGSGTPGPVGSPAPGHPAVSSMQGKRKALKLNFANPPFKSTARFT
LNPNPTGVQNPHIERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMV
HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL
MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS
GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL
ATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE
LLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVD
|
|
|
|---|
| BDBM50336457 |
|---|
| n/a |
|---|
| Name | BDBM50336457 |
|---|
| Synonyms: | (3S,5Z,8S,9R,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione | CHEMBL1077979 | CHEMBL1668411 | CHEMBL1801950 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H22O7 |
|---|
| Mol. Mass. | 362.3738 |
|---|
| SMILES | COc1cc(O)c2c(CCCC(=O)C(=O)C(=O)CCC[C@H](C)OC2=O)c1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
